OpenVSafe by OpenVAERS
Search V-safe

2AH-12861-90858

3 vaccinations 1 coded response 23 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
019 / MA
Registered
2021-03-20
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-15
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-20
    Registered in v-safe
  3. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Abdominal pain
    Adult check-in
  4. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-24
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  6. 2021-03-29
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  7. 2021-04-05
    Dose 2 — Pfizer-BioNTech
  8. 2021-04-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  9. 2021-04-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Muscle or body aches, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-04-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  11. 2021-04-12
    Health check-in — day 7, dose 2
    Feeling: Good · Muscle or body aches
    Adult check-in
  12. 2021-04-21
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-04-28
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  14. 2021-05-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-07-05
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-10-04
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  18. 2021-10-05
    Dose 3 — Pfizer-BioNTech
  19. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  20. 2021-10-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea
    Adult check-in
  21. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Nausea, Diarrhea, Abdominal pain
    Adult check-in
  22. 2021-10-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache
    Adult check-in
  23. 2021-10-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Nausea
    Adult check-in
  24. 2021-10-12
    Health check-in — day 7, dose 3
    Feeling: Fair · Nausea
    Adult check-in
  25. 2021-11-02
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  26. 2022-01-04
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  27. 2022-04-05
    Survey response — 6 months, dose 3
    MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Runny nose and cough
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-04-05
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  29. 2022-04-07
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12021-03-15Pfizer-BioNTech
22021-04-05Pfizer-BioNTech
32021-10-05Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-04-05 Successful
2022-04-07
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 11 — 6 months, dose 3

2022-04-05

Symptoms: Runny nose and cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release